At the Channing Division of Network Medicine (CDNM), we use an integrated, network-based, and systems biology-drive approach to understand, reclassify, and treat complex diseases. With access to 3.2 million specimens from 300,000 subjects, alongside renowned cohort study questionnaires and advanced computational analytics, CDNM is recognized for the uniqueness of its interdisciplinary scientific direction and cross-domain expertise. We welcome collaborative opportunities and encourage other researchers to explore potential opportunities.

CDNM currently has more than 80 Harvard Medical School (HMS) faculty and 42 postdoctoral research fellows and is supported by 160 non-faculty Brigham and Women’s Hospital (BWH) employees, who are primarily in research and administration.